Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. COHR
9. META
10. AMC

Go back to Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001
(NASDAQ: ETON) Delayed: 55.31 -0.19 (0.34%)
Previous Close $55.50    52 Week High $ 
Open $55.50    52 Week Low $ 
Day High $56.75    P/E N/A 
Day Low $53.60    EPS $ 
Volume 335,508